1. Home
  2. BBBY vs FBRX Comparison

BBBY vs FBRX Comparison

Compare BBBY & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBBY

Bed Bath & Beyond Inc.

HOLD

Current Price

$5.63

Market Cap

435.5M

Sector

N/A

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$27.32

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBBY
FBRX
Founded
1971
N/A
Country
United States
United States
Employees
389
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.5M
487.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BBBY
FBRX
Price
$5.63
$27.32
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$7.67
$67.00
AVG Volume (30 Days)
1.7M
385.9K
Earning Date
04-27-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.30
EPS
N/A
N/A
Revenue
N/A
$36,000.00
Revenue This Year
$6.35
N/A
Revenue Next Year
$7.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$6.50
52 Week High
$12.65
$35.80

Technical Indicators

Market Signals
Indicator
BBBY
FBRX
Relative Strength Index (RSI) 57.58 44.26
Support Level $5.43 $26.67
Resistance Level $5.96 $31.71
Average True Range (ATR) 0.36 3.16
MACD 0.11 -0.26
Stochastic Oscillator 67.78 20.92

Price Performance

Historical Comparison
BBBY
FBRX

About BBBY Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering products and services that enable its customers to enhance everyday life through quality, style, and value. The company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites, as well as a blockchain asset portfolio. Its e-commerce platforms, www.bedbathandbeyond.com and www.overstock.com, are targeted at customers seeking various products such as furniture, bedding, area rugs, tabletop and cookware, decor, storage, jewelry, etc, at affordable prices. In addition to products, the company also offers add-on services across platforms, including warranties, shipping insurance, and installation services.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: